The aim of this study was to examine the relationship between visual field (VF) loss, vision-related quality of life (QoL) and glaucoma-related symptoms in a large cohort of primary open angle glaucoma (POAG) patients. POAG patients with or without VF defects or "glaucoma suspect" patients were considered eligible. QoL was assessed using the validated versions of the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) and glaucoma-related symptoms were assessed using the Glaucoma Symptom Scale (GSS). Patients were classified as having VF damage in one eye (VFD-1), both eyes (VFD-2), or neither eye (VFD-0). 3227 patients were enrolled and 2940 were eligible for the analysis. 13.4% of patients were classified in the VFD-0, 23.7% in the VFD-1, and 62.9% in the VFD-2 group. GSS visual symptoms domain (Func-4) and GSS non-visual symptoms domain (Symp-6) scores were similar for the VFD-0 and VFD-1 groups (p = 0.133 and p = 0.834 for Func-4 and Symp-6, respectively). VFD-0 group had higher scores than VFD-2 both in Func-4 (p < 0.001) and Symp-6 domains (p = 0.035). Regarding the NEI-VFQ-25, our data demonstrated that bilateral VF defects are associated with vision-related QoL deterioration, irrespective of visual acuity.

Rulli, E., Quaranta, L., Riva, I., Poli, D., Hollander, L., Galli, F., et al. (2018). Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study. SCIENTIFIC REPORTS, 8(1) [10.1038/s41598-017-19113-z].

Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study

Manni G.;
2018-01-01

Abstract

The aim of this study was to examine the relationship between visual field (VF) loss, vision-related quality of life (QoL) and glaucoma-related symptoms in a large cohort of primary open angle glaucoma (POAG) patients. POAG patients with or without VF defects or "glaucoma suspect" patients were considered eligible. QoL was assessed using the validated versions of the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) and glaucoma-related symptoms were assessed using the Glaucoma Symptom Scale (GSS). Patients were classified as having VF damage in one eye (VFD-1), both eyes (VFD-2), or neither eye (VFD-0). 3227 patients were enrolled and 2940 were eligible for the analysis. 13.4% of patients were classified in the VFD-0, 23.7% in the VFD-1, and 62.9% in the VFD-2 group. GSS visual symptoms domain (Func-4) and GSS non-visual symptoms domain (Symp-6) scores were similar for the VFD-0 and VFD-1 groups (p = 0.133 and p = 0.834 for Func-4 and Symp-6, respectively). VFD-0 group had higher scores than VFD-2 both in Func-4 (p < 0.001) and Symp-6 domains (p = 0.035). Regarding the NEI-VFQ-25, our data demonstrated that bilateral VF defects are associated with vision-related QoL deterioration, irrespective of visual acuity.
2018
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/30 - MALATTIE APPARATO VISIVO
English
Rulli, E., Quaranta, L., Riva, I., Poli, D., Hollander, L., Galli, F., et al. (2018). Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study. SCIENTIFIC REPORTS, 8(1) [10.1038/s41598-017-19113-z].
Rulli, E; Quaranta, L; Riva, I; Poli, D; Hollander, L; Galli, F; Katsanos, A; Oddone, F; Torri, V; Weinreb, Rn; Varano, L; Carchedi, T; Talarico, S; Parravano, F; Motolese, I; Bagaglia, Sa; Rossi, Gcm; Lateri, S; Bossolesi, L; Carmassi, L; Rolle, T; Piccini, R; Ratiglia, R; Rossi, A; Gandolfi, S; Tagliavini, V; Ungaro, N; Fossarello, M; Cucca, A; Zucca, I; Uva, M; Bonacci, E; Cardarella, G; Tognetto, D; Vattovani, O; Vallon, P; Iannacone, F; Fontana, L; Marchi, S; Manni, G; Jannetta, D; Roberti, G; Rossetti, L; Maggiolo, E; Oneta, O; Sborgia, C; Cantatore, F; Mastropasqua, L; Agnifili, L; Campos, E; Gizzi, C; Giannaccare, G; Pucci, V; Cassamali, M; Costagliola, C; Traverso, C; Scotto, R; Musolino, M; Landi, L; Bagnis, A
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/314755
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 35
social impact